Literature DB >> 8331529

A method for the preparation of submicron particles of sparingly water-soluble drugs by precipitation in oil-in-water emulsions. I: Influence of emulsification and surfactant concentration.

B Sjöström1, B Kronberg, J Carlfors.   

Abstract

A method for the synthesis of small particles of poorly water-soluble drug substances with emulsions is presented. The drug is dissolved in an organic solvent and a water-soluble surfactant is dissolved in water. These two solutions are mixed to form an emulsion in which the organic solution is emulsified into small droplets in the aqueous phase. The surfactant decreases the interfacial tension between the water and the organic solution, and thus increases the ease of emulsification, and stabilizes the droplets formed against aggregation or coalescence. The final step includes removal of the organic solvent by evaporation. The drug precipitates and one particle is formed from each droplet. If the surfactant is sufficiently effective in stabilizing the particles formed against coagulation, a suspension of small spherical drug particles is formed. A model system consisting of cholesteryl acetate and toluene is described. Particles with a diameter as low as 50 nm were obtained. The particle size was dependent on the surfactant concentration and on the emulsification energy.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8331529     DOI: 10.1002/jps.2600820607

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  10 in total

1.  Nanoemulsion-based delivery systems for poorly water-soluble bioactive compounds: Influence of formulation parameters on Polymethoxyflavone crystallization.

Authors:  Yan Li; Jinkai Zheng; Hang Xiao; David Julian McClements
Journal:  Food Hydrocoll       Date:  2011-09-17       Impact factor: 9.147

2.  Nanoparticles of poorly water-soluble drugs prepared by supercritical fluid extraction of emulsions.

Authors:  Boris Y Shekunov; Pratibhash Chattopadhyay; Jeff Seitzinger; Robert Huff
Journal:  Pharm Res       Date:  2006-11-30       Impact factor: 4.200

3.  Celecoxib nanosuspension: single-step fabrication using a modified nanoprecipitation method and in vivo evaluation.

Authors:  Anju Malkani; Abhijit A Date; Darshana Hegde
Journal:  Drug Deliv Transl Res       Date:  2014-08       Impact factor: 4.617

4.  Supercooled smectic nanoparticles: a potential novel carrier system for poorly water soluble drugs.

Authors:  J Kuntsche; K Westesen; M Drechsler; M H J Koch; H Bunjes
Journal:  Pharm Res       Date:  2004-10       Impact factor: 4.200

5.  Influence of formulation and processing variables on properties of itraconazole nanoparticles made by advanced evaporative precipitation into aqueous solution.

Authors:  Stephanie Bosselmann; Masao Nagao; Keat T Chow; Robert O Williams
Journal:  AAPS PharmSciTech       Date:  2012-06-30       Impact factor: 3.246

6.  LipNanoCar Technology - A Versatile and Scalable Technology for the Production of Lipid Nanoparticles.

Authors:  Vera L R Esgueira; Clara P A Lopes; Ana Catarina A Dos Santos; Fátima Pinto; Silvia A Sousa; Dragana P C de Barros; Jorge H Leitão; Luis P Fonseca
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

7.  Structures of nanoparticles prepared from oil-in-water emulsions.

Authors:  B Sjöström; A Kaplun; Y Talmon; B Cabane
Journal:  Pharm Res       Date:  1995-01       Impact factor: 4.200

8.  Folate-targeted docetaxel-lipid-based-nanosuspensions for active-targeted cancer therapy.

Authors:  Lili Wang; Min Li; Na Zhang
Journal:  Int J Nanomedicine       Date:  2012-06-29

Review 9.  Alkyl ethoxylated and alkylphenol ethoxylated nonionic surfactants: interaction with bioactive compounds and biological effects.

Authors:  T Cserháti
Journal:  Environ Health Perspect       Date:  1995-04       Impact factor: 9.031

Review 10.  Encapsulation of Lipid-Soluble Bioactives by Nanoemulsions.

Authors:  Shahin Banasaz; Ksenia Morozova; Giovanna Ferrentino; Matteo Scampicchio
Journal:  Molecules       Date:  2020-08-31       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.